Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

PRN News Releases

Jul 12, 2024 04:00 ET
DouYu International Holdings Limited Announces Ex-dividend Date
WUHAN, China, July 12, 2024 /PRNewswire/ -- DouYu International Holdings Limited ("DouYu" or the "Company") (Nasdaq: DOYU) a leading game-centric live streaming platform in China and a pioneer in the eSports value chain, today announced that Nasdaq has set September 3, 2024 as the ex-dividend date for the special cash dividend that was announced on July 3, 2024. As the special cash dividend of US$9.76 per ordinary share, or US$9.76 per American Depositary Share ("ADS"), net of a handling fee of US$0.05 per ADS charged by the depositary bank, exceeds 25% of the Company's ADS price, pursuant t...
Jul 12, 2024 04:00 ET
Penetron Expands Customer Support Team in Key Western USA Market
On June 24th, 2024, Penetron announced the appointment of Jered Miller as Southwestern USA Account Manager, a key region where Penetron continues to rapidly grow its market share. This new appointment underlines the company's intent to further expand and strengthen the Penetron Technical and Customer Support teams....
Jul 12, 2024 03:42 ET
BioVaxys Technology Corp. Announces Revocation of Cease Trade Order
VANCOUVER, BC, July 12, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: BVAXF) (the "Company") is pleased to announce the revocation of the failure to file cease trade order (the "FFCTO") issued by its principal regulator, the Ontario Securities Commission (the "OSC"), on May 15, 2024....
Jul 12, 2024 03:41 ET
XCMG Machinery Ranks 63rd in China's Most Valuable Brands 2024, Leads Construction Equipment Industry for 11th Year
XUZHOU, China, July 12, 2024 /PRNewswire – XCMG Machinery (SHE: 000425, "XCMG") has secured the 63rd position in the "China's 500 Most Valuable Brands 2024" by World Brand Lab, with a brand value of CNY 127.136 billion (USD $17.474 billion). This achievement marks its eleventh consecutive year at the top of the construction machinery sector, reflecting its sustained leadership and innovative strategies....
Jul 12, 2024 03:26 ET
Smartee Denti-Technology Debuts Themed Airplane with Spring Airlines
SHANGHAI, July 12, 2024 /PRNewswire/ -- Smartee Denti-Technology, in partnership with Spring Airlines, unveiled its inaugural themed airplane at Shanghai Hongqiao International Airport. The event was part of Smartee's 20th-anniversary celebrations....
Jul 12, 2024 03:00 ET
"Salvează o inimă" Association innovates fundraising campaigns by integrating AI into its workflow
BOTOSANI, Romania, July 12, 2024 /PRNewswire/ -- "Salvează o inimă" Association launches an innovative project that integrates artificial intelligence technologies to support and streamline fundraising campaigns for children with extremely serious medical conditions. The project aims to address the need to provide prompt and efficient assistance to families who need to urgently pay for expensive and complex surgery and medical treatments, without which the lives of the patients would be put at risk....
Jul 12, 2024 03:00 ET
CREACT4MED program for the Mediterranean, Africa concludes with aid to over 400 people
BARCELONA, Spain, July 12, 2024 /PRNewswire/ -- The CREACT4MED program, co-financed by the European Union, held its closing event in Barcelona, Spain, highlighting the project's achievements in training over 400 individuals to establish businesses in the cultural and creative industries of Mediterranean and North African countries....
Jul 12, 2024 02:44 ET
MIRIDIH Raises $15M in Series B
*Accelerating Global Expansion and Growth*...
Jul 12, 2024 02:31 ET
Jul 12, 2024 01:30 ET
Following Is a Test Release
Jul 12, 2024 01:30 ET
XRP Healthcare LLC Successfully Registers Trademark in the UAE, Strengthening Global Expansion and Legal Compliance
DUBAI, UAE, July 12, 2024 /PRNewswire/ -- XRP Healthcare LLC is proud to announce the successful registration of its trademark in the United Arab Emirates (UAE). This milestone follows the company's strategic incorporation in the crypto-friendly Gulf state late last year and underscores its commitment to global expansion and brand protection....
Jul 12, 2024 01:00 ET
InventHelp Inventor Develops New Sprinkler De-Icing System (CLM-677)
PITTSBURGH, July 12, 2024 /PRNewswire/ -- "I thought there should be a way to use your in-ground water sprinkler to dispense liquid de-icing solution for snow and ice removal," said an inventor, from Wayne, Mich., "so I invented the DEICER SPRINKLER. My design allows you to easily remove winter accumulations without shoveling, plowing, or snow blowing."...
Jul 12, 2024 01:00 ET
Salvi, Schostok & Pritchard $32.7 Million Jury Verdict Ranked #1 among Top 10 Verdicts in Illinois for 2023
A $32.7 million jury verdict obtained by Salvi, Schostok & Pritchard has been ranked the 1st overall verdict in Top Verdict's Top 10 Personal Injury Verdicts in Illinois in 2023....
Jul 12, 2024 00:30 ET
This marks the fourth year of recognition continuing from 2023, 2021, and 2020The Leela Palace Bengaluru is ranked #1 in World's Best India City Hotel; #4 in World's Best Asia City Hotels and #36 in World's Best HotelThe Leela Palace New Delhi ranked #3 in World's Best India City Hotel; #9 in World's Best Asia City Hotels 62 in World's Best Hotel; and The Leela Palace Udaipur ranked#65 among the 100 Best Hotels in the WorldMUMBAI, India, July 12, 2024 /PRNewswire/ -- The Leela Palaces, Hotels and Resorts has once again been honoured for its distinction as a premier luxury global brand, as it...
Jul 12, 2024 00:15 ET
Lomax + Wood Reach New Soundproofing Rating of 49dB
Essex-based timber framed window specialist Lomax + Wood has raised the bar for their acoustic ratings on their timber window range....
Jul 11, 2024 23:30 ET
The Biggest Names in Sports Came Out for GBK Brand Bar's Pre ESPY Luxury Lounge Presented by MEND
Taking Place at the Ten Thousand Luxury Residences in Los Angeles, over $60K in Gifts and Trips were gifted to each of the world's top athletes present...
Jul 11, 2024 23:19 ET
Stellus Capital Investment Corporation Announces $0.40 Third Quarter 2024 Regular Dividend, Payable Monthly in Increments of $0.1333 in August, September, and October 2024
HOUSTON, July 11, 2024 /PRNewswire/ -- Stellus Capital Investment Corporation (the "Company") (NYSE: SCM) announced that its Board of Directors has declared a monthly dividend of $0.1333 for each of July, August, and September, totaling $0.40 per share in the aggregate for the third quarter of 2024. The regular dividend of $0.40 per share will be paid to shareholders of record in August, September, and October 2024....
Jul 11, 2024 22:59 ET
Leqembi approved for the treatment of Alzheimer's disease in Israel
STOCKHOLM, July 12, 2024 /PRNewswire/ -- BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai announced today that Leqembi® (generic name: lecanemab) has been approved for treatment of Alzheimer's disease (AD) in Israel. Treatment with Leqembi should be initiated in patients with mild cognitive impairment (MCI) or mild dementia stage of disease, the population in which treatment was initiated in clinical trials. Israel is the sixth territory to approve Leqembi following the US, Japan, China, South Korea and Hong Kong. ...
Jul 11, 2024 22:43 ET
The new vacation is set for its official debut on Friday, July 19, sailing 3-night weekend and 4-night weekday getaways to The Bahamas...
Jul 11, 2024 22:35 ET
Paige Bueckers and Candace Parker Present Highest Honor in High School Sports to Nation's Top Athletes...